| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 52.567 | 87.608 | 109.967 | 113.908 | 154.045 | 152.681 | 248.344 | 310.678 | 428.887 | 529.783 |
| Total Income - EUR | 52.567 | 87.608 | 109.968 | 113.910 | 154.220 | 161.913 | 248.389 | 310.904 | 429.659 | 532.526 |
| Total Expenses - EUR | 46.671 | 75.218 | 91.525 | 110.238 | 142.914 | 145.129 | 200.550 | 264.675 | 356.920 | 439.993 |
| Gross Profit/Loss - EUR | 5.896 | 12.390 | 18.444 | 3.672 | 11.305 | 16.784 | 47.838 | 46.229 | 72.739 | 92.533 |
| Net Profit/Loss - EUR | 4.319 | 11.514 | 17.344 | 2.539 | 9.763 | 15.828 | 45.634 | 43.648 | 69.087 | 80.514 |
| Employees | 4 | 5 | 6 | 8 | 9 | 10 | 9 | 8 | 9 | 10 |
Check the financial reports for the company - Neurodent S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.252 | 3.960 | 4.216 | 2.783 | 4.655 | 8.893 | 28.737 | 66.360 | 82.893 | 140.140 |
| Current Assets | 14.656 | 14.514 | 20.574 | 13.291 | 20.064 | 29.121 | 20.568 | 14.849 | 63.203 | 90.997 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 696 | 684 | 1.562 | 3.905 | 4.043 | 3.900 | 3.186 | 3.642 |
| Cash | 14.656 | 14.514 | 19.878 | 12.607 | 7.966 | 25.216 | 16.525 | 10.949 | 60.017 | 87.355 |
| Shareholders Funds | 13.097 | 11.567 | 17.397 | 6.949 | 16.577 | 32.091 | 45.683 | 52.119 | 121.047 | 200.885 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.837 | 6.931 | 7.418 | 9.161 | 8.184 | 5.953 | 3.979 | 29.044 | 24.440 | 30.118 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 112 | 782 | 666 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Neurodent S.r.l.